クイックアンサー — Semaxとは?
Semax is a synthetic heptapeptide based on the 4–10 fragment of adrenocorticotropic hormone (ACTH). Developed at the Institute of Molecular Genetics in Russia, it is a nootropic and neuroprotective peptide best known for potent BDNF上昇 KYC(Know Your Customer) 経鼻CNS送達. Approved in Russia as a stroke-recovery drug — not FDA-approved. Supplied in 5 mg to 10 mg lyophilized vials.
📦 すべてのご注文は、当店の 再発送保証ポリシー — 万が一、20営業日以内に商品が届かない場合は、再発送いたします。
| 仕様 | 詳細 |
|---|---|
| CAS番号 | 80714-61-0 |
| 分子式 | C37H51N9O10S |
| 分子量 | 813.93 Da |
| 配列 | Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP) |
| 形態 | 凍結乾燥粉末(または供給時の形態) |
| 純度 | ≥99%(HPLC検証済み、COAはご要望に応じて提供) |
| 保管方法 | 凍結乾燥品:使用時在庫は2~8℃(冷蔵)に保管。未開封バイアルの長期保管には−20℃。再溶解後:2~8℃で約30日以内に使用。光から保護してください。再溶解液の凍結融解は避けてください。 |
| 溶解性 | 静菌水(推奨)または短時間使用の場合は滅菌水 |
Semaxとは何ですか?
Semax (Met-Glu-His-Phe-Pro-Gly-Pro, sequence MEHFPGP) is a synthetic seven-amino-acid peptide developed in the 1980s at the Russian Institute of Molecular Genetics by Mekhedov, Malyshev, and collaborators. It is a structural analog of the ACTH 4–10 fragment — the central biologically-active region of adrenocorticotropic hormone — modified with a C-terminal Pro-Gly-Pro sequence that extends half-life and improves CNS penetration. Semax is ロシア連邦で承認されています as a prescription medication for acute ischemic stroke and cognitive-disorder indications, sold under the trade names Semax and Semaks. It is not approved by the FDA, EMA, or other Western regulators, so Western users access it through specialist supply. Molecular weight approximately 813.9 Da. Supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. Semax is for clinical studies use only outside its approved jurisdiction. For mechanism, clinical history, and context, see our Semax guide.
作用機序 — BDNF、メラノコルチン、およびCNS浸透性
Semax’s pharmacology combines three features that make it unusually well-studied for a nootropic peptide:
- BDNF上昇 — the most consistent observation across the Semax literature is rapid upregulation of 脳由来神経栄養因子(BDNF) 海馬および皮質で。BDNFはシナプス可塑性、ニューロン生存、長期記憶の固定化の主要調節因子であり;その上昇は観察された認知および神経保護効果の分子基盤として提案されています。
- メラノコルチン受容体関連活性 — SemaxはACTH 4-10に由来するため、MC3RおよびMC4Rに対する中程度の結合親和性を保持しています。このメラノコルチン受容体活性は、以下のような広範なMC類似体の末梢性日焼け関連効果とは異なります。 Melanotan II Semaxは中枢的に作用し、MC1Rを有意に活性化しないためです。
- 経鼻CNS送達 — Semaxは特に次の目的で設計されました: nose-to-brain administration. Intranasal delivery bypasses the blood-brain barrier via olfactory-epithelial and trigeminal pathways, producing rapid CNS exposure within minutes. This is the primary administration route and is how the approved Russian products are administered.
Additional reported mechanisms include attenuation of oxidative stress in neuronal study models, modulation of enkephalin and monoamine pathways, and effects on attention-related dopaminergic signaling — the combination that underpins ADHD-relevant contexts.
Published Evidence
Semax is used in clinical contexts that investigate:
- Cognitive studies — memory, attention, and executive-function studies in rodent behavioral models (Dolotov et al., J Neurochem 2006)
- Stroke recovery — 虚血性脳卒中のげっ歯類モデル。Semaxはロシアでこの適応症に対しヒトでの承認を取得しています。
- ADHD studies — げっ歯類行動モデルにおける注意/多動性の研究
- 神経保護 — oxidative-stress, glutamate toxicity, and neuronal-survival studies in aging models
- Mood studies — anxiety and depression behavioral studies in rodent models
- BDNF signaling studies — Semax is one of the most consistent peptide-based BDNF elevators available for preclinical studies (Kaplan et al., Neurosci Biobehav Rev 2022)
- Stacking studies — しばしば併用される NAD+ KYC(Know Your Customer) Epitalon in longevity / cognitive protocols
向知性薬および長寿ペプチドに関するより広い文脈については、 ペプチドカタログ.
利用可能な力価と濃度
MedsBaseでは、Semaxを以下の凍結乾燥バイアルサイズで取り扱っております:
| バイアル力価 | 代表的な使用例 | パックサイズ |
|---|---|---|
| 5 mg | Pilot dosing, short protocols | 10、20、または30バイアル |
| 10 mg | Standard strength — supports ~33 administrations at 300 mcg | 10、20、または30バイアル |
Semax can be administered either intranasally (the primary administration route) or subcutaneously as an SC-reference dosing arm. All strengths are supplied as lyophilized powder at 99%+ HPLC purity.
Semaxと他の認知/長寿ペプチド — 比較
Semax sits within a small group of nootropic and longevity peptides with published preclinical studies. Each uses a distinct mechanism:
| 評価項目 | Semax | Epitalon | NAD+ |
|---|---|---|---|
| 主な作用機序 | BDNF上昇、 | テロメラーゼ/松果体シグナル伝達 | サーチュイン/PARP補酵素 |
| Strongest signal | 認知機能、脳卒中回復 | テロメア長、概日リズム | 細胞エネルギー、長寿 |
| 主な投与経路 | 経鼻(皮下も可) | 皮下注射 | 皮下注射、筋肉内注射、静脈内注射 |
| 一般的な用量 | 経鼻で1日250~600 mcg | 皮下注射で1日5~10 mg | 皮下/筋肉内注射で1日50~100 mg |
| 規制 | ロシアで承認済み | 未承認 | 未承認 |
Users often study Semax together with Epitalon KYC(Know Your Customer) NAD+ in longevity / neurocognitive-aging protocols because their mechanisms are complementary.
保管方法と再溶解
再溶解前: 凍結乾燥バイアルは元の包装のまま2~8°Cで冷蔵保存し、最長36ヶ月間安定です。粉末の凍結融解サイクルは避けてください。 再溶解手順: for intranasal studies, reconstitute at a concentration matched to a nasal dropper or spray. For SC-reference dosing, follow the chart above. Swirl gently — do しません 振とう — そして完全に溶解するまで5~10分間放置します。 完全に再溶解した溶液は、無色透明である必要があります。 2~8°Cで冷蔵保存し、30日以内に使用してください。再構成後は凍結しないでください。
よくある質問
What is Semax used for in studies?
Semax is used in studies investigating cognitive function, memory, attention, stroke recovery, ADHD-relevant pathways, neuroprotection, mood / anxiety studies, and BDNF signaling. It is approved in Russia for ischemic-stroke treatment; in the US and EU it is しません FDA/EMA-approved and is sold here strictly for clinical studies use only.
How is Semax administered in studies?
The primary administration route is 経鼻, 、ロシア承認製品の投与形式に一致します。経鼻投与は、嗅覚経路を介して血液脳関門を迂回し、迅速な中枢神経系への到達を可能にします。一部のプロトコルでは、参照投与経路として皮下注射が使用されます。Semaxは胃酵素によって急速に分解されるため、経口投与は効果的ではありません。
What is the typical Semax dose?
Published preclinical and Russian-approved protocols typically use 250–600 mcg intranasally, 1–3 times daily. Some protocols use SC 100–300 mcg equivalent. A 10 mg vial reconstituted with 2.0 mL bacteriostatic water yields 5.0 mg/mL — 6 ticks on a U-100 SC syringe delivers 300 mcg.
SemaxはFDAに承認されていますか?
いいえ。Semaxは、ロシア連邦で急性虚血性脳卒中および認知障害の適応症に対して承認されていますが、 しません been approved by the FDA, EMA, MHRA, or any other Western regulator.
SemaxはBDNFにどのような作用を及ぼしますか?
Published studies consistently shows rapid and sustained upregulation of brain-derived neurotrophic factor (BDNF) expression in hippocampus and cortex following Semax administration. BDNF is a master regulator of synaptic plasticity and long-term memory consolidation, and its elevation is the proposed mechanistic basis for the cognitive and neuroprotective studies observations.
Semaxはどのように保管すべきですか?
凍結乾燥バイアル:2〜8°Cの冷蔵庫で元の包装のまま、最長36ヶ月安定。溶解後溶液:2〜8°Cの冷蔵庫で保存し、30日以内に使用。溶解後溶液は凍結しないでください。
How do I reconstitute Semax for intranasal studies?
For nasal delivery, reconstitute at a concentration matched to your nasal dropper or spray delivery volume. A 10 mg vial in 2 mL gives 5 mg/mL; a typical 50–100 mcL nasal spray volume then delivers 250–500 mcg per administration. Study protocols should target the specific per-spray volume of the delivery device used.
Can Semax be stacked with other peptides in studies?
可能です。Semaxは一般的に Epitalon KYC(Know Your Customer) NAD+ in longevity and cognitive-aging protocols. The mechanisms are complementary — BDNF-driven neurotrophic signaling (Semax), telomere / circadian (Epitalon), cellular-energy / sirtuins (NAD+).
MedsBaseではどの容量のレタルトルチドを取り揃えていますか?
MedsBaseでは、Semaxを5 mgおよび10 mgの凍結乾燥バイアルで取り扱っています。各容量は、10バイアル、20バイアル、または30バイアルのパックサイズでご利用いただけます。すべてのバイアルは99%以上のHPLC純度で供給され、ご要望に応じて分析証明書を発行いたします。
Does Semax cause side reported effects?
Published preclinical studies and Russian clinical-trial data report a clean safety profile. Minor transient nasal irritation after intranasal administration is the most commonly reported observation. No significant systemic side effects have been identified at standard doses.
Semaxの半減期はどのくらいですか?
Semax has a short plasma half-life of approximately 2–3 minutes when administered intranasally or subcutaneously, attributed to rapid proteolytic degradation. Despite rapid systemic clearance, Semax demonstrates prolonged cognitive effects in preclinical studies — estimated at 20–24 hours — due to sustained BDNF upregulation in the brain rather than direct receptor occupation.
How does Semax compare to Selank in studies?
Semax and Selank are both synthetic nootropic peptides with Russian origins, but with distinct pharmacological profiles. Semax activates the BDNF/TrkB pathway and shows stronger stimulatory and cognitive-enhancing effects in preclinical studies. Selank is derived from the immunomodulatory peptide tuftsin and has more pronounced anxiolytic properties. Studies stacks sometimes combine both for complementary cognitive and anxiolytic effects.
Semaxを国際配送で注文できますか?
Yes. MedsBase ships Semax worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. Orders ship in temperature-controlled packaging with full tracking.
Other Peptides for Recovery and Performance
- BPC-157 — Body Protection Compound — tendon, ligament, gut recovery
- TB-500 — Thymosin Beta-4 fragment — soft tissue and vascular recovery
- Ipamorelin — 選択的グレリン作動薬 — コルチゾール/プロラクチンを伴わないクリーンなGHパルス
- CJC-1295 with DAC — 半減期延長型GHRHアナログ
- GHK-Cu — Copper peptide — skin and connective tissue regeneration
参考文献
📖 Learn the science behind this peptide
エビデンスに基づく完全ガイドをお読みください: Semax — mechanism, Russian clinical history, and honest studies. Covers BDNF pharmacology, ACTH 4-10 origin, intranasal delivery protocols, dosing ranges, and comparative nootropic context.














レビュー
まだレビューはありません